Fundraising FoxIO Biotech
10 known investors
Find your way into IO Biotech
Sign up to see every warm intro you have to IO Biotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the IO Biotech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
IOBiotech appears to be a biotech company focused on oncology, with a founder who has extensive experience in cancer drug development and clinical advancement from roles at Roche, Eli Lilly, and leading academic cancer centers.
Founders & leadership
Investors · 10
How we know: Avoro Capital Advisors's portfolio page · funding news · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Kurma Partners's portfolio page · a partner's Signal profile · funding news · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Pivotal Life Sciences's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Samsara BioCapital's portfolio page · Not right? Tell us
How we know: Sunstone Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Vivo Capital's portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BJan 2021Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does IO Biotech do?
- IOBiotech appears to be a biotech company focused on oncology, with a founder who has extensive experience in cancer drug development and clinical advancement from roles at Roche, Eli Lilly, and leading academic cancer centers.
- Who are IO Biotech's investors?
- IO Biotech's investors include Avoro Capital Advisors, EIR Ventures, Kurma Partners, Pivotal Life Sciences, RA Capital, Samsara BioCapital, Sunstone Capital, Vivo Capital and 2 more.